IAG Capital Partners

VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, the company specializes in developing bioresorbable smart polymers specifically designed for vascular surgery. Its flagship product, SelfWrap, is a perivascular wrap that functions as an external stent to enhance the success of dialysis procedures. SelfWrap addresses complications at the vein-artery or vein-graft junction by promoting outward vein growth and providing customized mechanical support, thereby reducing the risk of vein collapse and occlusion. This innovative approach utilizes a new class of shape-memory polymers that do not require sutures, ultimately improving surgical outcomes, reducing operation time, and minimizing infection risks for hemodialysis patients. VenoStent aims to significantly impact the approximately 5 million vascular surgeries conducted annually, enhancing the quality and longevity of life for chronic kidney disease patients.

VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, the company specializes in developing bioresorbable smart polymers specifically designed for vascular surgery. Its flagship product, SelfWrap, is a perivascular wrap that functions as an external stent to enhance the success of dialysis procedures. SelfWrap addresses complications at the vein-artery or vein-graft junction by promoting outward vein growth and providing customized mechanical support, thereby reducing the risk of vein collapse and occlusion. This innovative approach utilizes a new class of shape-memory polymers that do not require sutures, ultimately improving surgical outcomes, reducing operation time, and minimizing infection risks for hemodialysis patients. VenoStent aims to significantly impact the approximately 5 million vascular surgeries conducted annually, enhancing the quality and longevity of life for chronic kidney disease patients.

VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, the company specializes in developing bioresorbable smart polymers specifically designed for vascular surgery. Its flagship product, SelfWrap, is a perivascular wrap that functions as an external stent to enhance the success of dialysis procedures. SelfWrap addresses complications at the vein-artery or vein-graft junction by promoting outward vein growth and providing customized mechanical support, thereby reducing the risk of vein collapse and occlusion. This innovative approach utilizes a new class of shape-memory polymers that do not require sutures, ultimately improving surgical outcomes, reducing operation time, and minimizing infection risks for hemodialysis patients. VenoStent aims to significantly impact the approximately 5 million vascular surgeries conducted annually, enhancing the quality and longevity of life for chronic kidney disease patients.

Path Ex, Inc. is a Nashville, Tennessee-based company founded in 2017 that specializes in the manufacture of extracorporeal blood cleansing equipment. The company has developed a proprietary technology aimed at selectively separating and capturing bacteria and toxins from human blood, specifically for the treatment of sepsis, a critical condition often linked to blood-borne infections. Unlike conventional methods that rely on antibiotics to combat infections, Path Ex's innovative approach focuses on removing intact bacteria from the bloodstream, making it effective against various bacteria types and drug-resistant strains. This technology has the potential to significantly improve patient outcomes by reducing diagnostic times, lowering treatment costs, decreasing readmission rates, and ultimately decreasing sepsis-related mortality.